Article Details
Retrieved on: 2025-03-11 18:13:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA's draft guidance on accelerated approval for biopharmaceuticals, focusing on expediting life-saving treatments. Experts like Cicchini and Gorman highlight the importance of understanding critical quality attributes and strategic planning to succeed in this pathway.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here